share_log

PetVivo (OTCMKTS:PETV) Share Price Passes Above Fifty Day Moving Average of $1.99

PetVivo (OTCMKTS:PETV) Share Price Passes Above Fifty Day Moving Average of $1.99

PetVivo(OTCMKTS:PETV)股价突破50日移动均线1.99美元
Defense World ·  2022/08/16 03:41

PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.99 and traded as high as $2.35. PetVivo shares last traded at $2.33, with a volume of 19,235 shares traded.

PetVivo Holdings,Inc.(OTCMKTS:PETV-GET评级)在周一的交易中突破了50日移动均线。该股的50日移动均线为1.99美元,交易价格高达2.35美元。PetVivo的股票最新报2.33美元,成交量为19,235股。

PetVivo Price Performance

PetVivo性价比

The stock has a market cap of $23.22 million, a price-to-earnings ratio of -3.10 and a beta of 1.96. The company has a current ratio of 4.15, a quick ratio of 4.00 and a debt-to-equity ratio of 0.01. The stock has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $1.83.

该股市值为2322万美元,市盈率为-3.10倍,贝塔系数为1.96。该公司的流动比率为4.15,速动比率为4.00,债务权益比率为0.01。该股的50日移动均线价格为1.99美元,200日移动均线价格为1.83美元。

Get
到达
PetVivo
PetVivo
alerts:
警报:

Institutional Investors Weigh In On PetVivo

机构投资者看好PetVivo

An institutional investor recently raised its position in PetVivo stock. Vanguard Group Inc. increased its position in shares of PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) by 5.2% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 226,137 shares of the company's stock after purchasing an additional 11,251 shares during the quarter. Vanguard Group Inc. owned approximately 2.31% of PetVivo worth $461,000 as of its most recent filing with the SEC. 13.70% of the stock is currently owned by hedge funds and other institutional investors.

一家机构投资者最近提高了对PetVivo股票的头寸。根据先锋集团向美国证券交易委员会披露的最新信息,今年第一季度,先锋集团将PetVivo Holdings,Inc.的股票头寸增加了5.2%。该机构投资者在本季度额外购买了11,251股后,持有226,137股该公司股票。截至最近向美国证券交易委员会提交的文件,先锋集团持有PetVivo约2.31%的股份,价值46.1万美元。13.70%的股票目前由对冲基金和其他机构投资者持有。

About PetVivo

关于PetVivo

(Get Rating)
(获取评级)

PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.

PetVivo控股公司是一家生物医疗设备公司,从事治疗动物疾病和疾病的医疗设备和生物材料的制造、商业化和许可。它的主要产品是Spryng,一种由兽医管理的关节内注射,用于治疗跛行和其他关节疾病,如狗和马的骨关节炎。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on PetVivo (PETV)
  • 3 Blowout Earnings Reports That Could Mark Turning Points
  • Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
  • Skyworks Solutions Is Worth A Look At These Prices
  • 3 Stocks Set to Lead the Nasdaq Bull Market
  • MarketBeat Podcast: ESG – Profitably Invest Your Values
  • 免费获取StockNews.com关于PetVivo的研究报告(PETV)
  • 3份井喷式收益报告可能标志着转折点
  • CrowdStrike是否会延续其盈利排行榜榜首的势头?
  • Skyworks Solutions值得看看这些价格
  • 3只股票将引领纳斯达克牛市
  • MarketBeat播客:ESG--有利可图地投资你的价值

Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.

接受PetVivo Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对PetVivo和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发